Capri­cor Ther­a­peu­tics failed to win the back­ing of an FDA ad­vi­so­ry pan­el for de­ramio­cel, a ther­a­py in­tend­ed to slow the rate of de­cline in car­diac func­tion in pa­tients with Duchenne mus­cu­lar dy­s­tro­phy...